Global Neurosyphilis Market Research Report 2023

Report ID: 1988709 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neurosyphilis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Asymptomatic Neurosyphilis
        1.2.3 Meningeal Neurosyphilis
        1.2.4 Meningovascular Neurosyphilis
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Neurosyphilis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital & Clinics
        1.3.3 Medical Research Centers
        1.3.4 Academic Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neurosyphilis Market Perspective (2017-2028)
    2.2 Neurosyphilis Growth Trends by Region
        2.2.1 Neurosyphilis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neurosyphilis Historic Market Size by Region (2017-2022)
        2.2.3 Neurosyphilis Forecasted Market Size by Region (2023-2028)
    2.3 Neurosyphilis Market Dynamics
        2.3.1 Neurosyphilis Industry Trends
        2.3.2 Neurosyphilis Market Drivers
        2.3.3 Neurosyphilis Market Challenges
        2.3.4 Neurosyphilis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neurosyphilis Players by Revenue
        3.1.1 Global Top Neurosyphilis Players by Revenue (2017-2022)
        3.1.2 Global Neurosyphilis Revenue Market Share by Players (2017-2022)
    3.2 Global Neurosyphilis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neurosyphilis Revenue
    3.4 Global Neurosyphilis Market Concentration Ratio
        3.4.1 Global Neurosyphilis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neurosyphilis Revenue in 2021
    3.5 Neurosyphilis Key Players Head office and Area Served
    3.6 Key Players Neurosyphilis Product Solution and Service
    3.7 Date of Enter into Neurosyphilis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neurosyphilis Breakdown Data by Type
    4.1 Global Neurosyphilis Historic Market Size by Type (2017-2022)
    4.2 Global Neurosyphilis Forecasted Market Size by Type (2023-2028)
5 Neurosyphilis Breakdown Data by Application
    5.1 Global Neurosyphilis Historic Market Size by Application (2017-2022)
    5.2 Global Neurosyphilis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neurosyphilis Market Size (2017-2028)
    6.2 North America Neurosyphilis Market Size by Country (2017-2022)
    6.3 North America Neurosyphilis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Neurosyphilis Market Size (2017-2028)
    7.2 Europe Neurosyphilis Market Size by Country (2017-2022)
    7.3 Europe Neurosyphilis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neurosyphilis Market Size (2017-2028)
    8.2 Asia-Pacific Neurosyphilis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Neurosyphilis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Neurosyphilis Market Size (2017-2028)
    9.2 Latin America Neurosyphilis Market Size by Country (2017-2022)
    9.3 Latin America Neurosyphilis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neurosyphilis Market Size (2017-2028)
    10.2 Middle East & Africa Neurosyphilis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Neurosyphilis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Neurosyphilis Introduction
        11.1.4 Abbott Revenue in Neurosyphilis Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Neurosyphilis Introduction
        11.2.4 Bayer Revenue in Neurosyphilis Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Detail
        11.3.2 Eli Lilly and Company Business Overview
        11.3.3 Eli Lilly and Company Neurosyphilis Introduction
        11.3.4 Eli Lilly and Company Revenue in Neurosyphilis Business (2017-2022)
        11.3.5 Eli Lilly and Company Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Neurosyphilis Introduction
        11.4.4 GlaxoSmithKline Revenue in Neurosyphilis Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Neurosyphilis Introduction
        11.5.4 Novartis Revenue in Neurosyphilis Business (2017-2022)
        11.5.5 Novartis Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Detail
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Neurosyphilis Introduction
        11.6.4 Pfizer Revenue in Neurosyphilis Business (2017-2022)
        11.6.5 Pfizer Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Detail
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Neurosyphilis Introduction
        11.7.4 Sanofi Revenue in Neurosyphilis Business (2017-2022)
        11.7.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Neurosyphilis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Asymptomatic Neurosyphilis
    Table 3. Key Players of Meningeal Neurosyphilis
    Table 4. Key Players of Meningovascular Neurosyphilis
    Table 5. Key Players of Others
    Table 6. Global Neurosyphilis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Neurosyphilis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Neurosyphilis Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Neurosyphilis Market Share by Region (2017-2022)
    Table 10. Global Neurosyphilis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Neurosyphilis Market Share by Region (2023-2028)
    Table 12. Neurosyphilis Market Trends
    Table 13. Neurosyphilis Market Drivers
    Table 14. Neurosyphilis Market Challenges
    Table 15. Neurosyphilis Market Restraints
    Table 16. Global Neurosyphilis Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Neurosyphilis Market Share by Players (2017-2022)
    Table 18. Global Top Neurosyphilis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosyphilis as of 2021)
    Table 19. Ranking of Global Top Neurosyphilis Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Neurosyphilis Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Neurosyphilis Product Solution and Service
    Table 23. Date of Enter into Neurosyphilis Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Neurosyphilis Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Neurosyphilis Revenue Market Share by Type (2017-2022)
    Table 27. Global Neurosyphilis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Neurosyphilis Revenue Market Share by Type (2023-2028)
    Table 29. Global Neurosyphilis Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Neurosyphilis Revenue Market Share by Application (2017-2022)
    Table 31. Global Neurosyphilis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Neurosyphilis Revenue Market Share by Application (2023-2028)
    Table 33. North America Neurosyphilis Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Neurosyphilis Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Neurosyphilis Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Neurosyphilis Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Neurosyphilis Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Neurosyphilis Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Neurosyphilis Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Neurosyphilis Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Neurosyphilis Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Neurosyphilis Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Abbott Company Detail
    Table 44. Abbott Business Overview
    Table 45. Abbott Neurosyphilis Product
    Table 46. Abbott Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 47. Abbott Recent Development
    Table 48. Bayer Company Detail
    Table 49. Bayer Business Overview
    Table 50. Bayer Neurosyphilis Product
    Table 51. Bayer Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 52. Bayer Recent Development
    Table 53. Eli Lilly and Company Company Detail
    Table 54. Eli Lilly and Company Business Overview
    Table 55. Eli Lilly and Company Neurosyphilis Product
    Table 56. Eli Lilly and Company Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 57. Eli Lilly and Company Recent Development
    Table 58. GlaxoSmithKline Company Detail
    Table 59. GlaxoSmithKline Business Overview
    Table 60. GlaxoSmithKline Neurosyphilis Product
    Table 61. GlaxoSmithKline Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 62. GlaxoSmithKline Recent Development
    Table 63. Novartis Company Detail
    Table 64. Novartis Business Overview
    Table 65. Novartis Neurosyphilis Product
    Table 66. Novartis Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. Pfizer Company Detail
    Table 69. Pfizer Business Overview
    Table 70. Pfizer Neurosyphilis Product
    Table 71. Pfizer Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 72. Pfizer Recent Development
    Table 73. Sanofi Company Detail
    Table 74. Sanofi Business Overview
    Table 75. Sanofi Neurosyphilis Product
    Table 76. Sanofi Revenue in Neurosyphilis Business (2017-2022) & (US$ Million)
    Table 77. Sanofi Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurosyphilis Market Share by Type: 2021 VS 2028
    Figure 2. Asymptomatic Neurosyphilis Features
    Figure 3. Meningeal Neurosyphilis Features
    Figure 4. Meningovascular Neurosyphilis Features
    Figure 5. Others Features
    Figure 6. Global Neurosyphilis Market Share by Application in 2021 & 2028
    Figure 7. Hospital & Clinics Case Studies
    Figure 8. Medical Research Centers Case Studies
    Figure 9. Academic Institutes Case Studies
    Figure 10. Neurosyphilis Report Years Considered
    Figure 11. Global Neurosyphilis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Neurosyphilis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Neurosyphilis Market Share by Region: 2021 VS 2028
    Figure 14. Global Neurosyphilis Market Share by Players in 2021
    Figure 15. Global Top Neurosyphilis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosyphilis as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Neurosyphilis Revenue in 2021
    Figure 17. North America Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Neurosyphilis Market Share by Country (2017-2028)
    Figure 19. United States Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Neurosyphilis Market Share by Country (2017-2028)
    Figure 23. Germany Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Neurosyphilis Market Share by Region (2017-2028)
    Figure 31. China Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Neurosyphilis Market Share by Country (2017-2028)
    Figure 39. Mexico Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Neurosyphilis Market Share by Country (2017-2028)
    Figure 43. Turkey Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Neurosyphilis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Abbott Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 46. Bayer Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 47. Eli Lilly and Company Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 51. Sanofi Revenue Growth Rate in Neurosyphilis Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Frequently Asked Questions
Neurosyphilis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neurosyphilis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neurosyphilis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Non Dairy Cheese

The research report includes specific segments by region (country), by company, by Source and by  ... Read More

Non Lethal Weapons

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More